Estrella Immunopharma Inc (ESLA)

10:16 AM

Will Estrella Immunopharma Inc. stock benefit from interest rate changesFree Investment Community - jammulinksnews.com

10:16 AM

06:48 AM

Why Estrella Immunopharma Inc. stock attracts strong analyst attentionBreakout Momentum Alerts - Newser

06:48 AM

Jul 24, 2025

What analysts say about Estrella Immunopharma Inc. stockConsistently superior profits - PrintWeekIndia

Jul 24, 2025

Jul 23, 2025

What drives Estrella Immunopharma Inc. stock priceFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

Estrella Immunopharma Inc. Stock Analysis and ForecastFree Stock Market Return Analysis - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Estrella Immunopharma Inc. a good long term investmentDynamic portfolio growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

How Estrella Immunopharma Inc. stock performs during market volatilityHigh Yield Stock Selection - Newser

Jul 22, 2025

Jul 18, 2025

how estrella immunopharma inc. stock performs during market volatilityCapital Efficient Investment Tips - Newser

Jul 18, 2025

Jul 18, 2025

Is Estrella Immunopharma Inc. stock overhyped or has real potentialSolid Return Trade Selections - Newser

Jul 18, 2025

Jul 16, 2025

What makes Estrella Immunopharma Inc. stock price move sharplyTop Growth Low Risk Stocks - Newser

Jul 16, 2025

Jun 07, 2025

Estrella Immunopharma Expands STARLIGHT-1 Trial with New Texas Clinical Site - MSN

Jun 07, 2025

Jun 05, 2025

Estrella Immunopharma opens new trial site for cancer therapy By Investing.com - Investing.com South Africa

Jun 05, 2025

Jun 05, 2025

Estrella Immunopharma Announces Activation of Additional Site for Phase I/II Starlight-1 Trial in B-Cell Non-Hodgkin's Lymphoma - MarketScreener

Jun 05, 2025

Jun 05, 2025

Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace

Jun 05, 2025

Jun 05, 2025

Estrella Immunopharma (ESLA) Expands Clinical Trial with New Sit - GuruFocus

Jun 05, 2025

Jun 05, 2025

Estrella Immunopharma opens new trial site for cancer therapy - Investing.com Australia

Jun 05, 2025

Jun 05, 2025

Estrella Immunopharma Expands STARLIGHT-1 Clinical Trial - TipRanks

Jun 05, 2025

Jun 05, 2025

Estrella Immunopharma Announces Activation Of Additional Site For Phase I/Ii Starlight-1 Trial In B-Cell Non-Hodgkin'S Lymphoma - marketscreener.com

Jun 05, 2025

Jun 04, 2025

Estrella Immunopharma secures $3.35M in financing to advance clinical triall; shares up - MSN

Jun 04, 2025

Jun 04, 2025

Analyst Maintains Buy Rating on Estrella Immunopharma (ESLA) | E - GuruFocus

Jun 04, 2025

Jun 04, 2025

Estrella Immunopharma secures $3.35 million in PIPE financing By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 03, 2025

Analyst Maintains Buy Rating on Estrella Immunopharma (ESLA) | ESLA Stock News - GuruFocus

Jun 03, 2025

Jun 03, 2025

Estrella Immunopharma (ESLA) Secures $3.35M Through Private Equi - GuruFocus

Jun 03, 2025